RedShift BioAnalytics’ $20 Million Series E Financing

Foley Hoag advised RedShift BioAnalytics on the deal.RedShift BioAnalytics Inc. (RedShiftBio), a company providing next-generation platform technology enabling measurement of previously undetectable structure changes in biomolecules,…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now